Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

OpenAI is working on something big, developing its own brain-computer interface. But what does this actually mean?

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.

Cognixion’s Vision Pro study shows how Apple’s accessibility framework is shaping the future of healthcare and communication ...

On this episode of Uncanny Valley, we dive into the heated race between two companies to build a commercial brain-computer interface. All products featured on WIRED are independently selected by our ...

Everyone – ourselves included – is talking about AI these days, for good reason. AI models now draft legal contracts, design chips, code software, edit videos, discover drugs, even run autonomous labs ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Christopher Mims: Tim, what do you think is the hottest show on television right ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...